Cargando…
Response to cardiac resynchronization therapy and treatment with ARNi and iSGLT2
FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. BACKGROUND: Heart failure with reduced ejection fraction (HFrEF) is associated in about one third of patients with abnormal conduction of the cardiac electrical impulse, resulting in asynchronous activation of the ventricles and worsening of c...
Autores principales: | Fonderico, C, Faccenda, D, Pergola, V, Marrese, A, Comparone, G, Meola, M, Salucci, A, Cocchiara, L, Addeo, L, Ammirati, G, Rapacciuolo, A, Strisciuglio, T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207545/ http://dx.doi.org/10.1093/europace/euad122.460 |
Ejemplares similares
-
The prevalence and importance of frailty in cardiac resynchronization therapy patients
por: Kuthi, L, et al.
Publicado: (2023) -
Epicardial versus endocardial pacing in cardiac resynchronization therapy
por: Marciniak, M, et al.
Publicado: (2023) -
What determines who gets cardiac resynchronization therapy in europe?
por: Gatti, P, et al.
Publicado: (2023) -
Left-bundle branch block, an alert for cardiac resynchronization therapy
por: Gatti, P, et al.
Publicado: (2023) -
Hemodynamic optimization of cardiac resynchronization therapy by heart sound sensor in pulse generator
por: Prinzen, F, et al.
Publicado: (2023)